These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6874726)

  • 21. Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine.
    Kassis AI; Guptill WE; Taube RA; Adelstein SJ
    J Nucl Biol Med (1991); 1991; 35(3):167-73. PubMed ID: 1840093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
    Journe F; Laurent G; Chaboteaux C; Nonclercq D; Durbecq V; Larsimont D; Body JJ
    Breast Cancer Res Treat; 2008 Jan; 107(1):49-61. PubMed ID: 17333335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific cytotoxicity of 16 alpha-[125I]iodoestradiol for estrogen receptor-containing breast cancer cells.
    Bronzert DA; Hochberg RB; Lippman ME
    Endocrinology; 1982 Jun; 110(6):2177-82. PubMed ID: 7075553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotoxicity of 17 alpha-[125I]iodovinyl-11 beta-methoxyestradiol in MCF-7 human breast cancer cells.
    Epperly MW; Damodaran KM; McLaughlin WH; Pillai KM; Bloomer WD
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):729-34. PubMed ID: 1958509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electromagnetic fields alter the expression of estrogen receptor cofactors in breast cancer cells.
    Girgert R; Gründker C; Emons G; Hanf V
    Bioelectromagnetics; 2008 Apr; 29(3):169-76. PubMed ID: 18027843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
    Pihie AH; Stanslas J; Din LB
    Anticancer Res; 1998; 18(3A):1739-43. PubMed ID: 9673398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.
    Narra VR; Howell RW; Harapanhalli RS; Sastry KS; Rao DV
    J Nucl Med; 1992 Dec; 33(12):2196-201. PubMed ID: 1460515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
    Marcsek Z; Kocsis Z; Jakab M; Szende B; Tompa A
    Cancer Biother Radiopharm; 2004 Dec; 19(6):746-53. PubMed ID: 15665622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells.
    Oldham RK; Herberman RB
    J Immunol; 1973 Dec; 111(6):862-71. PubMed ID: 4750872
    [No Abstract]   [Full Text] [Related]  

  • 34. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA damage induced in human diploid cells by decay of incorporated radionuclides.
    LeMotte PK; Little JB
    Cancer Res; 1984 Apr; 44(4):1337-42. PubMed ID: 6704953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The toxicity of fluorodeoxyuridine when used to increase the uptake of 125I-iododeoxyuridine into tissue culture cells in vitro.
    Holmes JM
    J Comp Pathol; 1983 Oct; 93(4):531-9. PubMed ID: 6227637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of mitochondrial DNA in cell death induced by 125I decay.
    Yasui LS; Hofer KG
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Apr; 49(4):601-10. PubMed ID: 3485602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breaks in DNA accompany estrogen-receptor-mediated cytotoxicity from 16 alpha[125I]iodo-17 beta-estradiol.
    Beckmann MW; Scharl A; Rosinsky BJ; Holt JA
    J Cancer Res Clin Oncol; 1993; 119(4):207-14. PubMed ID: 8423195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary observations of malignant melanoma therapy using radiolabeled alpha-methyltyrosine.
    McLaughlin WH; Thramann WM; Lambrecht RM; Milius RA; Bloomer WD
    J Surg Oncol; 1988 Mar; 37(3):192-7. PubMed ID: 3352274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cell inactivation by Auger electrons using the two reagents 4-[123I]iodoantipyrine and [123I]NaI.
    Smit BS; Slabbert JP; Reinecke SA; Böhm L
    Radiat Environ Biophys; 2001 Mar; 40(1):47-52. PubMed ID: 11357710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.